The table below shows Cytosorbents Corp's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$1.16M
-$3.47M
-$4.83M
-$3.11M
-$8.12M
-$2.34M
Capital expenditure
$11.00K
$2.00K
$45.19K
$509.67K
$710.24K
$428.64K
Investing cash flow
-$46.00K
-$47.00K
-$127.02K
-$682.88K
-$847.96K
-$606.34K
Dividends paid
-
-
-
CTSO operating cash flow (10-K history)
Cytosorbents Corp reported operating cash flow of -$12.38M for fiscal year 2025. That is up 14.2% from -$14.43M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$6.73M (FY 2016) to -$12.38M. Figures come from the company's audited annual reports as filed with the SEC.